Trace Biosciences prepared its first IND submission using Weave Bio's Submission Builder.

A first-time IND sponsor with tight timelines had to coordinate scientific input and keep regulatory modules consistent as data changed. The team used Weave Bio's Submission Builder with structured drafting templates and AI-assisted drafting under human scientific oversight. The page says drafting and revision time fell and the first IND was submitted; it gives no figures.

Weave Bio is an AI-native regulatory automation platform, used by pharma, biotech and CROs to draft IND and NDA content and respond to health authority questions

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.